Search

everythinglearnresearchcommunity

for

Search:↓

GCN reduces lung inflammation and damage from air pollution in mice.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Key proteins and potential drugs for treating alopecia areata were identified.

Fissistigma oldhamii has compounds that help with pain, inflammation, and other health issues.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Polygonum multiflorum may help treat hair loss but can be toxic to the liver.

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

Melatonin may treat rosacea and Alzheimer's by reducing inflammation and affecting blood vessel growth.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

New treatments for severe alopecia areata show promise but lack standard approval.

Tofacitinib is effective and safe for treating severe alopecia areata.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Leptin, a hormone, is important for starting hair growth.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Baricitinib effectively regrows hair in severe alopecia areata cases.

New treatments offer hope for better managing hidradenitis suppurativa.

Indigofera tinctoria leaf extract has many compounds that support its traditional medicinal uses.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.